SpiroChem Acquires Cyclenium Pharma to Strengthen its Portfolio in Macrocyclic Therapeutics
BASEL, SWITZERLAND, June 6, 2023 /EINPresswire.com/ -- SpiroChem, an Elite Contract Research Organization (CRO) headquartered in Basel, Switzerland, announced the acquisition of Cyclenium Pharma, a Montreal-based company specializing in the design and …